Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine Nasal Spray for Spinal Anesthesia Success in Knee/Hip Replacement
ChiCTR2500114414Phase 4Not yet recruiting
- Sponsor
- Qingdao Municipal Hospital
- Start
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of dexmedetomidine in knee osteoarthritis (OA) and hip osteoarthritis (2 arms), sponsored by Qingdao Municipal Hospital. Primary endpoints: First-attempt spinal anesthesia puncture success rate and Satisfaction score during spinal anesthesia process. Planned start Dec 2025; status: not yet recruiting.
02
Drugs
dexmedetomidine
03
Conditions
knee osteoarthritis (OA)hip osteoarthritis
Beyond the preview
Go deeper on ChiCTR2500114414.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500114414.